×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VOR – vor biopharma inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VOR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
10:22 am
vor
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Medium
Report
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
12/15
08:00 am
vor
Vor Bio Announces $150 Million Private Placement
Medium
Report
Vor Bio Announces $150 Million Private Placement
12/10
11:24 am
vor
Vor Biopharma (VOR): Valuation Check After Positive Telitacicept Phase 3 Data and Upbeat JPMorgan Coverage [Yahoo! Finance]
Low
Report
Vor Biopharma (VOR): Valuation Check After Positive Telitacicept Phase 3 Data and Upbeat JPMorgan Coverage [Yahoo! Finance]
12/9
08:07 am
vor
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $43.00 price target on the stock.
Medium
Report
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $43.00 price target on the stock.
11/25
09:06 am
vor
Vor Biopharma (NASDAQ:VOR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
Medium
Report
Vor Biopharma (NASDAQ:VOR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
11/14
08:09 am
vor
Vor Biopharma (NASDAQ:VOR) had its price target lowered by analysts at HC Wainwright from $55.00 to $32.00. They now have a "buy" rating on the stock.
Low
Report
Vor Biopharma (NASDAQ:VOR) had its price target lowered by analysts at HC Wainwright from $55.00 to $32.00. They now have a "buy" rating on the stock.
11/13
07:23 am
vor
Vor Biopharma (NASDAQ:VOR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Medium
Report
Vor Biopharma (NASDAQ:VOR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/10
09:56 pm
vor
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
High
Report
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/17
04:00 pm
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: GREAT POINT PARTNERS LLC
Low
Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: GREAT POINT PARTNERS LLC
12/9
08:00 am
vor
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Mahatme Sandesh
Low
Report
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Mahatme Sandesh
12/9
08:00 am
vor
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Zuraw Qing Che
Low
Report
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Zuraw Qing Che
12/9
08:00 am
vor
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Kress Jean-Paul
Low
Report
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Kress Jean-Paul
12/9
07:59 am
vor
Form 8-K Vor Biopharma Inc. For: Dec 05
Low
Report
Form 8-K Vor Biopharma Inc. For: Dec 05
11/18
04:30 pm
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
High
Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
11/14
06:13 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: